 <h1>Binimetinib Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to binimetinib: oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, binimetinib may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking binimetinib:</p><p>
<i>More common</i>
</p><ul>
<li>Bleeding gums</li>
<li>bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>blurred vision or any other change in vision</li>
<li>chest pain</li>
<li>coughing up blood</li>
<li>decreased urine output</li>
<li>difficulty in breathing or swallowing</li>
<li>dilated neck veins</li>
<li>dizziness</li>
<li>extreme tiredness or weakness</li>
<li>fever</li>
<li>headache</li>
<li>hoarseness</li>
<li>increased menstrual flow or vaginal bleeding</li>
<li>irregular breathing</li>
<li>irregular heartbeat</li>
<li>irritation</li>
<li>itching, hives, skin rash</li>
<li>joint pain, stiffness, or swelling</li>
<li>nervousness</li>
<li>nosebleed</li>
<li>paralysis</li>
<li>pounding in the ears</li>
<li>prolonged bleeding from cuts</li>
<li>rapid weight gain</li>
<li>red or black, tarry stools</li>
<li>red or dark brown urine</li>
<li>redness of the skin</li>
<li>slow or fast heartbeat</li>
<li>stomach cramps</li>
<li>tenderness</li>
<li>tightness in the chest</li>
<li>tingling of the hands or feet</li>
<li>trouble seeing</li>
<li>unusual tiredness or weakness</li>
<li>unusual weight gain or loss</li>
<li>watery or bloody diarrhea</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of binimetinib may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Constipation</li>
<li>diarrhea</li>
<li>nausea</li>
<li>stomach pain</li>
<li>vomiting</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to binimetinib: oral tablet</i></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Anemia (36%), hemorrhage (19%), leukopenia (13%), lymphoma (13%), neutropenia (13%)</p>
<p><b>Common</b> (1% to 10%): Venous thromboembolism (VTE)<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Hypersensitivity<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Rhabdomyolysis<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Retinopathy (20%), visual impairment (20%)</p>
<p><b>Common</b> (1% to 10%): Retinal detachment, macular edema, uveitis</p>
<p><b>Uncommon</b> (0.1% to 1%): Retinal vein occlusion<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Hyponatremia (18%), peripheral edema (13%)<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Increased gamma glutamyl transferase (45%)</p>
<p><b>Common</b> (1% to 10%): Alanine aminotransferase (ALT) increased, aspartate aminotransferase (AST) increased </p>
<p><b>Uncommon</b> (0.1% to 1%): Alkaline phosphatase increased<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Uncommon</b> (0.1% to 1%): Interstitial lung disease<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (43%), pyrexia (18%)<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dizziness (15%)<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very common</b> (10% or more): Increased creatinine (93%), increased creatine phosphokinase (58%)<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hypertension (11%)</p>
<p><b>Common</b> (1% to 10%): Cardiomyopathy, fatal intracranial hemorrhage (in the setting of new or progressive brain metastases)<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Rash (22%)</p>
<p><b>Common</b> (1% to 10%): Panniculitis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (41%), diarrhea (36%), vomiting (30%), abdominal pain (28%), constipation (22%)</p>
<p><b>Common</b> (1% to 10%): Rectal hemorrhage, hematochezia, hemorrhoidal hemorrhage, colitis<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Mektovi (binimetinib)." Array BioPharma Inc., Boulder, CO. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>What is Mektovi used to treat?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about binimetinib</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>Drug class: multikinase inhibitors</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Binimetinib &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Mektovi</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Melanoma, Metastatic</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to binimetinib: oral tablet</i></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Anemia (36%), hemorrhage (19%), leukopenia (13%), lymphoma (13%), neutropenia (13%)</p><p><b>Common</b> (1% to 10%): Venous thromboembolism (VTE)<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Hypersensitivity<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Rhabdomyolysis<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Retinopathy (20%), visual impairment (20%)</p><p><b>Common</b> (1% to 10%): Retinal detachment, macular edema, uveitis</p><p><b>Uncommon</b> (0.1% to 1%): Retinal vein occlusion<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Hyponatremia (18%), peripheral edema (13%)<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Increased gamma glutamyl transferase (45%)</p><p><b>Common</b> (1% to 10%): Alanine aminotransferase (ALT) increased, aspartate aminotransferase (AST) increased </p><p><b>Uncommon</b> (0.1% to 1%): Alkaline phosphatase increased<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Uncommon</b> (0.1% to 1%): Interstitial lung disease<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (43%), pyrexia (18%)<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dizziness (15%)<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very common</b> (10% or more): Increased creatinine (93%), increased creatine phosphokinase (58%)<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hypertension (11%)</p><p><b>Common</b> (1% to 10%): Cardiomyopathy, fatal intracranial hemorrhage (in the setting of new or progressive brain metastases)<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Rash (22%)</p><p><b>Common</b> (1% to 10%): Panniculitis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (41%), diarrhea (36%), vomiting (30%), abdominal pain (28%), constipation (22%)</p><p><b>Common</b> (1% to 10%): Rectal hemorrhage, hematochezia, hemorrhoidal hemorrhage, colitis<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Mektovi (binimetinib)." Array BioPharma Inc., Boulder, CO. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What is Mektovi used to treat?</li>
</ul><h2>More about binimetinib</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>Drug class: multikinase inhibitors</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Binimetinib &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Melanoma, Metastatic</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>